FineMark National Bank & Trust’s ResMed RMD Stock Holding History

FineMark National Bank & Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,000	Closed	-$62K	–	864
2016 Q4	$62K	Sell	1,000 -700	-41%	-$42.9K	0.01%	580
2016 Q3	$110K	Buy	1,700 +400	+31%	+$26.6K	0.01%	433
2016 Q2	$82K	Buy	+1,300	New	+$76.6K	0.01%	487

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FineMark National Bank & Trust's RMD Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of ResMed (RMD) in Q1 2017, closing a stake of 1,000 shares — an estimated $62K sold.

FineMark National Bank & Trust first reported a position in RMD in Q2 2016 and held it in 3 quarters. The position peaked at $110K in Q3 2016. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.

FineMark National Bank & Trust reported no remaining ResMed position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 1,000 ResMed shares in Q1 2017, an estimated $62K.
FineMark National Bank & Trust first reported a position in ResMed in Q2 2016 and held it in 3 quarters.
FineMark National Bank & Trust's ResMed position peaked at $110K in Q3 2016.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.